Christiano M.V. Barbosa
Federal University of São Paulo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christiano M.V. Barbosa.
Chemico-Biological Interactions | 2009
Carlos Rocha Oliveira; Christiano M.V. Barbosa; Fábio D. Nascimento; Camilla S. Lanetzki; Marília B. Meneghin; Flávia E.G. Pereira; Edgar J. Paredes-Gamero; Alice T. Ferreira; Tiago Rodrigues; Mary Luci de Souza Queiroz; Antonio C.F. Caires; Ivarne L.S. Tersariol; Claudia Bincoletto
Previous studies reported by our group have introduced a new antitumoural drug called Biphosphinic Palladacycle Complex (BPC). In this paper we show that BPC causes apoptosis in leukaemia cells (HL60 and Jurkat), but not in normal human lymphocytes. IC(50) values obtained for both cell lines using the MTT and trypan blue exclusion assays 5h after BPC treatment were lower than 8.0 microM. Using metachromatic fluorophore, acridine orange, we observed that BPC elicited lysosomal rupture of leukaemic cells. Furthermore, BPC triggered caspase-3 and caspase-6 activation and apoptosis in cell lines, inducing chromatin condensation, apoptotic bodies, and DNA fragmentation. Interestingly, the lysosomal cathepsin B inhibitor CA074 markedly decreased BPC-induced caspase-3 and caspase-6 activation as well as cell death. Lysosomal BPC-induced membrane destabilisation was not dependent on reactive oxygen species generation, which was consistent with the absence of cellular HL60 and Jurkat membrane lipid peroxidation. We conclude that, following BPC treatment, lysosomal membrane rupture precedes cell death and the apoptotic signalling pathway is initiated by the release of cathepsin B in the cytoplasm of leukaemia cells. As no toxic effects for human lymphocytes were observed, we suggest that BPC is more selective for transformed cells, mainly due to their exacerbated lysosome expression.
Journal of Cellular Physiology | 2011
Carlos M.M.P. Leon; Christiano M.V. Barbosa; Giselle Z. Justo; Primavera Borelli; José Dias Resende Junior; José Salvador Rodrigues de Oliveira; Alice T. Ferreira; Edgar J. Paredes-Gamero
Even though the involvement of intracellular Ca2+ (
European Journal of Pharmacology | 2012
Andrana K. Calgarotto; Gustavo J.S. Pereira; Alexandre Bechara; Edgar J. Paredes-Gamero; Christiano M.V. Barbosa; Hanako Hirata; Mary Luci de Souza Queiroz; Soraya S. Smaili; Claudia Bincoletto
{\rm Ca}_{{\rm i}}^{{\rm 2 + }}
Journal of Leukocyte Biology | 2011
Amanda Nogueira-Pedro; Christiano M.V. Barbosa; Helena Regina Comodo Segreto; Lisandro Lungato; Vania DˈAlmeida; Andrea Aparecida de Fátima Souza Moraes; Antonio Miranda; Edgar J. Paredes-Gamero; Alice T. Ferreira
) in hematopoiesis has been previously demonstrated, the relationship between
Food and Chemical Toxicology | 2011
Mary Luci de Souza Queiroz; Michelle C. da Rocha; Cristiane O. Torello; Julia de Souza Queiroz; Claudia Bincoletto; Marcelo Antonio Morgano; Miriam R. Romano; Edgar J. Paredes-Gamero; Christiano M.V. Barbosa; Andrana K. Calgarotto
{\rm Ca}_{{\rm i}}^{{\rm 2 + }}
Frontiers in Bioscience | 2012
Edgar J. Paredes-Gamero; Christiano M.V. Barbosa; Alice T. Ferreira
signaling and cytokine‐induced intracellular pathways remains poorly understood. Herein, the molecular mechanisms integrating Ca2+ signaling with the extracellular signal‐regulated kinase 1/2 (ERK1/2) pathway in primary murine and human hematopoietic stem/progenitor cells stimulated by IL‐3 and GM‐CSF were studied. Our results demonstrated that IL‐3 and GM‐CSF stimulation induced increased inositol 1,4,5‐trisphosphate (IP3) levels and
Journal of Cellular Biochemistry | 2014
Christiano M.V. Barbosa; Claudia Bincoletto; Carlos C. Barros; Alice T. Ferreira; Edgar J. Paredes-Gamero
{\rm Ca}_{{\rm i}}^{{\rm 2 + }}
Chemico-Biological Interactions | 2010
Carlos Rocha Oliveira; Edgar J. Paredes-Gamero; Christiano M.V. Barbosa; Fábio D. Nascimento; Elice C. Batista; Felipe C.G. Reis; Antonio H. Martins; Alice T. Ferreira; Adriana K. Carmona; João Bosco Pesquero; Ivarne L.S. Tersariol; Ronaldo C. Araujo; Claudia Bincoletto
release in murine and human hematopoietic stem/progenitor cells. In addition,
Brain Behavior and Immunity | 2013
Julia de Souza Queiroz; Christiano M.V. Barbosa; Michelle C. da Rocha; Claudia Bincoletto; Edgar J. Paredes-Gamero; Mary Luci de Souza Queiroz; João Palermo Neto
{\rm Ca}_{{\rm i}}^{{\rm 2 + }}
Peptides | 2013
Carol C. Dias; Amanda Nogueira-Pedro; Christiano M.V. Barbosa; Antonio C. Ribeiro-Filho; Frederick Wasinski; Ronaldo C. Araujo; Vani Xavier Oliveira; Antonio Miranda; Edgar J. Paredes-Gamero
signaling inhibitors, such as inositol 1,4,5‐trisphosphate receptor antagonist (2‐APB), PKC inhibitor (GF109203), and CaMKII inhibitor (KN‐62), blocked phosphorylation of MEK activated by IL‐3 and GM‐CSF, suggesting the participation of Ca2+‐dependent kinases in MEK activation. In addition, we identify phospholipase Cγ2 (PLCγ2) as a PLCγ responsible for the induction of Ca2+ release by IL‐3 and GM‐CSF in hematopoietic stem/progenitor cells. Furthermore, the PLCγ inhibitor U73122 significantly reduced the numbers of granulocyte‐macrophage colony‐forming units after cytokine stimulation. Similar results were obtained in both murine and human hematopoietic stem/progenitor cells. Taken together, these data indicate a role for PLCγ2 and Ca2+ signaling through the modulation of MEK in both murine and human hematopoietic stem/progenitor cells. J. Cell. Physiol. 226: 1780–1792, 2011.